Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Sogani

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
Seminars in Urology|August 1, 1990
Neoadjuvant chemotherapy for bladder cancer: the MSKCC experienceW R Fair, H Scher, H Herr, et al.
Cancer|January 15, 1992
High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better toleratedR J Motzer, S C Gulati, J P Crown, et al.
Cancer|March 1, 1991
Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989)R J Motzer, N L Geller, C C Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1986
VAB-6: an effective chemotherapy regimen for patients with germ-cell tumorsG J Bosl, R Gluckman, N L Geller, et al.
Cancer|December 15, 1990
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumorsR J Motzer, K Cooper, N L Geller, et al.
Annals of Internal Medicine|April 1, 1988
Advanced seminoma: the role of chemotherapy and adjunctive surgeryR J Motzer, G J Bosl, N L Geller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumorsG J Bosl, N L Geller, N J Vogelzang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional studyD F Bajorin, M F Sarosdy, D G Pfister, et al.
Urology|March 1, 1997
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center resultsW R Fair, M S Cookson, N Stroumbakis, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
Seminars in Urology|August 1, 1990
Neoadjuvant chemotherapy for bladder cancer: the MSKCC experienceW R Fair, H Scher, H Herr, et al.
Cancer|January 15, 1992
High-dose chemotherapy and autologous bone marrow rescue for patients with refractory germ cell tumors. Early intervention is better toleratedR J Motzer, S C Gulati, J P Crown, et al.
Cancer|March 1, 1991
Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989)R J Motzer, N L Geller, C C Tan, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1986
VAB-6: an effective chemotherapy regimen for patients with germ-cell tumorsG J Bosl, R Gluckman, N L Geller, et al.
Cancer|December 15, 1990
The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumorsR J Motzer, K Cooper, N L Geller, et al.
Annals of Internal Medicine|April 1, 1988
Advanced seminoma: the role of chemotherapy and adjunctive surgeryR J Motzer, G J Bosl, N L Geller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 1987
Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumorsG J Bosl, N L Geller, N J Vogelzang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 1993
Randomized trial of etoposide and cisplatin versus etoposide and carboplatin in patients with good-risk germ cell tumors: a multiinstitutional studyD F Bajorin, M F Sarosdy, D G Pfister, et al.
Urology|March 1, 1997
The indications, rationale, and results of neoadjuvant androgen deprivation in the treatment of prostatic cancer: Memorial Sloan-Kettering Cancer Center resultsW R Fair, M S Cookson, N Stroumbakis, et al.
Pageof 3